Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
2 Sept 2021 → 1 Sept 2024
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Egils Vjaters is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
State research project in the field of biomedicine, medical technologies and pharmacy
Lejnieks, A., Karelis, G., Gardovska, D., Ābola, Z., Miklaševičs, E., Daneberga, Z., Gardovskis, J., Pētersons, A., Kļaviņš, K., Kroiča, J., Skadiņš, I., Vīksna, L., Dimiņa, E., Sniedze, D., Karlsons, J., Broks, R., Gravele, D., Rozentālberga, A., Knoka, E., Konrāde, I., Trušinskis, K., Strēle, I., Kalinin, A., Ķīvīte-Urtāne, A., Radziņš, O., Bāgante, I., Koļesova, O., Nora-Krūkle, Z., Koļesovs, A., Mičule, M., Grāvelsiņa, S., Rasa-Dzelzkalēja, S., Kande, L., Nakazawa (Miklasevica), M., Vjaters, E., Lietuvietis, V., Plonis, J., Bitiņa-Barlote, Ē., Ieviņa, L., Fortūna, K., Pētersons, A., Pastare, D., Pugovičs, O., Silina, S. & Zemčugova-Bērziņa, A.
1/12/22 → 30/11/24
Project: National Research Programme
-
Imaging performance of multiparametric US and cross-sectional CT and MRI biomarkers using multimodal approach in the evaluation of renal masses to define standardized diagnostic algorithms
Radziņa, M., Vjaters, E., Briede, I., Liepa, M., Saule, L. & Putriņš, D. S.
1/04/22 → 31/03/23
Project: RSU grants
-
Impact of Targeted Molecular Imaging with 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in Multimodal Evaluation of Recurrent Prostate
Radziņa, M., Vjaters, E., Roznere, L., Liepa, M., Saule, L., Lioznovs, A., Mamis, E. & Ratniece, M.
1/01/20 → 31/12/22
Project: Fundamental and Applied Research Programme
-
A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases
Thellenberg-Karlsson, C., Vjaters, E., Kase, M., Tammela, T., Ojamaa, K., Norming, U., Nyman, C., Andersson, S. O., Hublarovs, O., Marquez-Holmberg, M., Castellanos, E., Ullen, A., Holmberg, A. & Nilsson, S., Mar 2023, In: European Journal of Cancer. 181, p. 198-207 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Can we predict Gleason score using MRI ADC values in clinically significant prostate cancer?
Bušs, A., Birkenfelds, E., Miculis, K., Vjaters, E., Liepa, M., Miķelsone, M. & Radzina, M., 9 May 2023.Research output: Contribution to conference › Poster › peer-review
Open Access -
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial
Bögemann, M., Shore, N. D., Smith, M. R., Tammela, T. L. J., Ulys, A., Vjaters, E., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Lebret, T., Schostak, M., Verholen, F., Le Berre, M. A., Srinivasan, S., Ortiz, J., Mohamed, A. F., Sarapohja, T. & Fizazi, K., Mar 2023, In: European Urology. 83, 3, p. 212-221 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Erratum to “Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial” [Eur Urol 2022] (European Urology, (S0302283822025325), (10.1016/j.eururo.2022.07.018))
Bögemann, M., Shore, N. D., Smith, M. R., Tammela, T. L. J., Ulys, A., Vjaters, E., Polyakov, S., Jievaltas, M., Luz, M., Alekseev, B., Lebret, T., Schostak, M., Verholen, F., Le Berre, M-A., Srinivasan, S., Ortiz, J., Mohamed, A. F., Sarapohja, T. & Fizazi, K., Feb 2023, In: European Urology. 83, 2, p. e60 1 p.Research output: Contribution to journal › Erratum › peer-review
Open Access1 Citation (Scopus) -
Is 18F-PSMA-1007 PET/CT feasible for bone metastases diagnosis in recurrent prostate cancer - the current status.
Saule, L., Radzina, M., Liepa, M., Roznere, L., Lioznovs, A., Ratniece, M., Mamis, E. & Vjaters, E., 9 May 2023, p. C-13783.Research output: Contribution to conference › Poster › peer-review
Open Access
Datasets
-
Recurrent prostate cancer diagnostic with 68Ga-PSMA-11 PET/CT
Radziņa, M. (Creator), Liepa, M. (Creator), Roznere, L. (Creator), Zemniece, L. (Creator), Saule, L. (Creator), Kalniņa, M. (Creator), Lietuvietis, V. (Creator), Freimanis, A. (Creator) & Vjaters, E. (Creator), Riga Stradins University, 21 Jun 2021
DOI: 10.48510/FK2/IJO02B, https://dataverse.rsu.lv/dataset.xhtml?persistentId=doi:10.48510/FK2/IJO02B
Dataset
Activities
-
PSMA ligand imaging challenges in recurrent prostate cancer
Laura Saule (Speaker), Maija Radziņa (Co-author), Māra Liepa (Co-author), Lilita Roznere (Co-author), Marika Kalniņa (Co-author), Andrejs Lioznovs (Co-author), Edgars Mamis (Co-author) & Egils Vjaters (Co-author)
8 Oct 2022Activity: Talk or presentation types › Oral presentation
-
Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 PET/CT for the detection of local recurrence and lymph node metastases in biochemical recurrence of prostate cancer
Laura Saule (Speaker), Maija Radziņa (Co-author), Māra Liepa (Co-author), Andrejs Lioznovs (Co-author), Lilita Roznere (Co-author), Liene Friebe (Co-author), Marika Kalniņa (Co-author), Edgars Mamis (Co-author) & Egils Vjaters (Co-author)
2 Mar 2022 → 6 Mar 2022Activity: Talk or presentation types › Poster presentation
-
Long-term safety of darolutamide in patients with metastatic castration- resistant prostate cancer
Egils Vjaters (Speaker)
17 Feb 2022Activity: Talk or presentation types › Poster presentation
-
Time course profile of adverse events of interest and serious adverse events with darolutamide in the ARAMIS trial
Christian Gratzke (Speaker), Egils Vjaters (Co-author), Karim Fizazi (Co-author), N. D. Shore (Co-author), Matthew R. Smith (Co-author), S. Feyerabend (Co-author), M. Grabbert (Co-author), J. Carles (Co-author), T. Lebret (Co-author), P. Werbrouck (Co-author), M. Miskic (Co-author), J. Ortiz (Co-author), A. Schmall (Co-author), Marie Aude Le Berre (Co-author) & F. Verholen (Co-author)
18 Sept 2021Activity: Talk or presentation types › Poster presentation
-
RSU Research week 2021: Knowledge for Use in Practice (Event)
Egils Vjaters (Reviewer of conference paper)
24 Mar 2021Activity: Publication peer-review and editorial work types › Publication Peer-review